Enzon Inc. (NASDAQ:ENZN) on Thursday said it has reached anagreement to use its Pegnology technology in the developmentof a therapeutic tissue repair protein with AllelixBiopharmaceuticals Inc. (Toronto:AXB).
The collaboration will combine the South Plainfield, N.J.,company's drug delivery technology with Allelix's epidermalgrowth factor.
The Mississauga, Ontario, company's protein has application intissue repair and ophthalmic wounds. The Pegnologytechnology extends the life of proteins circulating in the bloodstream and lowers their immunogenicity.
Financial terms weren't disclosed.
(c) 1997 American Health Consultants. All rights reserved.